ID   TRPD_SULSO              Reviewed;         345 AA.
AC   P50384;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-JUL-2015, entry version 113.
DE   RecName: Full=Anthranilate phosphoribosyltransferase {ECO:0000255|HAMAP-Rule:MF_00211};
DE            EC=2.4.2.18 {ECO:0000255|HAMAP-Rule:MF_00211};
GN   Name=trpD {ECO:0000255|HAMAP-Rule:MF_00211};
GN   OrderedLocusNames=SSO0890;
OS   Sulfolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 /
OS   P2).
OC   Archaea; Crenarchaeota; Thermoprotei; Sulfolobales; Sulfolobaceae;
OC   Sulfolobus.
OX   NCBI_TaxID=273057;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=DSM 5833 / MT-4;
RA   Tutino M.L., Cubellis M., Sannia G., Marino G.;
RT   "The tryptophan operon in Sulfolobus solfataricus.";
RL   Submitted (JUL-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 35092 / DSM 1617 / JCM 11322 / P2;
RX   PubMed=11427726; DOI=10.1073/pnas.141222098;
RA   She Q., Singh R.K., Confalonieri F., Zivanovic Y., Allard G.,
RA   Awayez M.J., Chan-Weiher C.C.-Y., Clausen I.G., Curtis B.A.,
RA   De Moors A., Erauso G., Fletcher C., Gordon P.M.K.,
RA   Heikamp-de Jong I., Jeffries A.C., Kozera C.J., Medina N., Peng X.,
RA   Thi-Ngoc H.P., Redder P., Schenk M.E., Theriault C., Tolstrup N.,
RA   Charlebois R.L., Doolittle W.F., Duguet M., Gaasterland T.,
RA   Garrett R.A., Ragan M.A., Sensen C.W., Van der Oost J.;
RT   "The complete genome of the crenarchaeon Sulfolobus solfataricus P2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:7835-7840(2001).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   CRYSTALLIZATION, AND SUBUNIT.
RX   PubMed=11298741; DOI=10.1046/j.1432-1327.2001.02102.x;
RA   Ivens A., Mayans O., Szadkowski H., Wilmanns M., Kirschner K.;
RT   "Purification, characterization and crystallization of thermostable
RT   anthranilate phosphoribosyltransferase from Sulfolobus solfataricus.";
RL   Eur. J. Biochem. 268:2246-2252(2001).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS,
RP   AND SUBUNIT.
RX   PubMed=12093726; DOI=10.1093/emboj/cdf298;
RA   Mayans O., Ivens A., Nissen L.J., Kirschner K., Wilmanns M.;
RT   "Structural analysis of two enzymes catalysing reverse metabolic
RT   reactions implies common ancestry.";
RL   EMBO J. 21:3245-3254(2002).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.56 ANGSTROMS) IN COMPLEX WITH
RP   PHOSPHORIBOSYLPYROPHOSPHATE, ANTHRANILATE AND MAGNESIUM IONS,
RP   FUNCTION, MUTAGENESIS OF LYS-106; HIS-107; HIS-154; ARG-164; ASP-223
RP   AND GLU-224, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=16714288; DOI=10.1074/jbc.M601403200;
RA   Marino M., Deuss M., Svergun D.I., Konarev P.V., Sterner R.,
RA   Mayans O.;
RT   "Structural and mutational analysis of substrate complexation by
RT   anthranilate phosphoribosyltransferase from Sulfolobus solfataricus.";
RL   J. Biol. Chem. 281:21410-21421(2006).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH
RP   PHOSPHORIBOSYLPYROPHOSPHATE AND MAGNESIUM IONS, AND SUBUNIT.
RX   PubMed=19385665; DOI=10.1021/bi802335s;
RA   Schlee S., Deuss M., Bruning M., Ivens A., Schwab T., Hellmann N.,
RA   Mayans O., Sterner R.;
RT   "Activation of anthranilate phosphoribosyltransferase from Sulfolobus
RT   solfataricus by removal of magnesium inhibition and acceleration of
RT   product release.";
RL   Biochemistry 48:5199-5209(2009).
CC   -!- FUNCTION: Catalyzes the transfer of the phosphoribosyl group of 5-
CC       phosphorylribose-1-pyrophosphate (PRPP) to anthranilate to yield
CC       N-(5'-phosphoribosyl)-anthranilate (PRA). {ECO:0000255|HAMAP-
CC       Rule:MF_00211, ECO:0000269|PubMed:11298741,
CC       ECO:0000269|PubMed:16714288}.
CC   -!- CATALYTIC ACTIVITY: N-(5-phospho-D-ribosyl)-anthranilate +
CC       diphosphate = anthranilate + 5-phospho-alpha-D-ribose 1-
CC       diphosphate. {ECO:0000255|HAMAP-Rule:MF_00211,
CC       ECO:0000269|PubMed:11298741}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 2 magnesium ions per monomer.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=50 uM for magnesium (at 60 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:11298741, ECO:0000269|PubMed:16714288};
CC         KM=40 nM for anthranilate (at 60 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:11298741, ECO:0000269|PubMed:16714288};
CC         KM=160 uM for phosphoribosylpyrophosphate (at 60 degrees Celsius
CC         and at pH 7.5) {ECO:0000269|PubMed:11298741,
CC         ECO:0000269|PubMed:16714288};
CC         KM=20 nM for anthranilate (at 25 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:11298741, ECO:0000269|PubMed:16714288};
CC         KM=26 nM for anthranilate (at 40 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:11298741, ECO:0000269|PubMed:16714288};
CC         KM=32 nM for anthranilate (at 50 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:11298741, ECO:0000269|PubMed:16714288};
CC         KM=35 nM for anthranilate (at 60 degrees Celsius and at pH 7.5)
CC         {ECO:0000269|PubMed:11298741, ECO:0000269|PubMed:16714288};
CC         KM=500 nM for anthranilate (at 87 degrees Celsius and at pH 7.5
CC         {ECO:0000269|PubMed:11298741, ECO:0000269|PubMed:16714288};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-tryptophan biosynthesis; L-
CC       tryptophan from chorismate: step 2/5. {ECO:0000255|HAMAP-
CC       Rule:MF_00211}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_00211,
CC       ECO:0000269|PubMed:11298741, ECO:0000269|PubMed:12093726,
CC       ECO:0000269|PubMed:16714288, ECO:0000269|PubMed:19385665}.
CC   -!- SIMILARITY: Belongs to the anthranilate phosphoribosyltransferase
CC       family. {ECO:0000255|HAMAP-Rule:MF_00211}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z50014; CAA90309.1; -; Genomic_DNA.
DR   EMBL; AE006641; AAK41173.1; -; Genomic_DNA.
DR   PIR; F90239; F90239.
DR   RefSeq; NP_342383.1; NC_002754.1.
DR   RefSeq; WP_009992305.1; NC_002754.1.
DR   PDB; 1GXB; X-ray; 2.70 A; A/B/C/D=1-345.
DR   PDB; 1O17; X-ray; 2.05 A; A/B/C/D=1-345.
DR   PDB; 1ZXY; X-ray; 2.56 A; A/B/C/D=1-345.
DR   PDB; 1ZYK; X-ray; 2.40 A; A/B/C/D=1-345.
DR   PDB; 2GVQ; X-ray; 2.43 A; A/B/C/D=1-345.
DR   PDB; 3GBR; X-ray; 2.25 A; A/B=1-345.
DR   PDBsum; 1GXB; -.
DR   PDBsum; 1O17; -.
DR   PDBsum; 1ZXY; -.
DR   PDBsum; 1ZYK; -.
DR   PDBsum; 2GVQ; -.
DR   PDBsum; 3GBR; -.
DR   ProteinModelPortal; P50384; -.
DR   SMR; P50384; 1-345.
DR   STRING; 273057.SSO0890; -.
DR   EnsemblBacteria; AAK41173; AAK41173; SSO0890.
DR   GeneID; 1455140; -.
DR   KEGG; sso:SSO0890; -.
DR   eggNOG; COG0547; -.
DR   HOGENOM; HOG000230451; -.
DR   InParanoid; P50384; -.
DR   KO; K00766; -.
DR   OMA; ARMTHES; -.
DR   BioCyc; SSOL273057:GCH2-847-MONOMER; -.
DR   BRENDA; 2.4.2.18; 6163.
DR   UniPathway; UPA00035; UER00041.
DR   EvolutionaryTrace; P50384; -.
DR   Proteomes; UP000001974; Chromosome.
DR   GO; GO:0004048; F:anthranilate phosphoribosyltransferase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0000162; P:tryptophan biosynthetic process; IEA:UniProtKB-HAMAP.
DR   Gene3D; 3.40.1030.10; -; 2.
DR   HAMAP; MF_00211; TrpD; 1.
DR   InterPro; IPR005940; Anthranilate_Pribosyl_Tfrase.
DR   InterPro; IPR000312; Glycosyl_Trfase_fam3.
DR   InterPro; IPR017459; Glycosyl_Trfase_fam3_N_dom.
DR   Pfam; PF02885; Glycos_trans_3N; 1.
DR   Pfam; PF00591; Glycos_transf_3; 1.
DR   SUPFAM; SSF47648; SSF47648; 1.
DR   SUPFAM; SSF52418; SSF52418; 1.
DR   TIGRFAMs; TIGR01245; trpD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis;
KW   Aromatic amino acid biosynthesis; Complete proteome;
KW   Glycosyltransferase; Magnesium; Metal-binding; Reference proteome;
KW   Transferase; Tryptophan biosynthesis.
FT   CHAIN         1    345       Anthranilate phosphoribosyltransferase.
FT                                /FTId=PRO_0000154523.
FT   REGION       77     79       Phosphoribosylpyrophosphate binding.
FT   REGION       82     83       Phosphoribosylpyrophosphate binding.
FT   REGION       89     92       Phosphoribosylpyrophosphate binding.
FT   REGION      106    114       Phosphoribosylpyrophosphate binding.
FT   METAL        91     91       Magnesium 1.
FT   METAL       223    223       Magnesium 2.
FT   METAL       224    224       Magnesium 1.
FT   METAL       224    224       Magnesium 2.
FT   BINDING      79     79       Anthranilate 1; via carbonyl oxygen.
FT   BINDING      87     87       Phosphoribosylpyrophosphate.
FT                                {ECO:0000255|HAMAP-Rule:MF_00211,
FT                                ECO:0000269|PubMed:16714288,
FT                                ECO:0000269|PubMed:19385665}.
FT   BINDING     109    109       Anthranilate 1.
FT   BINDING     118    118       Phosphoribosylpyrophosphate; via amide
FT                                nitrogen. {ECO:0000255|HAMAP-
FT                                Rule:MF_00211,
FT                                ECO:0000269|PubMed:16714288,
FT                                ECO:0000269|PubMed:19385665}.
FT   BINDING     164    164       Anthranilate 2.
FT   MUTAGEN     106    106       K->Q: Affinity for
FT                                phosphoribosylpyrophosphate is similar to
FT                                that of the wild-type enzyme and
FT                                catalytic efficiency dedreases only 10-
FT                                fold. {ECO:0000269|PubMed:16714288}.
FT   MUTAGEN     107    107       H->A: Limited effect on either affinity
FT                                for anthranilate and catalytic
FT                                efficiency. 300-fold decrease of the
FT                                affinity for anthranilate, whereas
FT                                catalytic efficiency remains nearly
FT                                unchanged; when associated with A-178.
FT                                {ECO:0000269|PubMed:16714288}.
FT   MUTAGEN     154    154       H->A: Limited effect on either affinity
FT                                for anthranilate and catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:16714288}.
FT   MUTAGEN     164    164       R->A: Strong decrease of the affinity for
FT                                anthranilate, although only a moderate 7-
FT                                fold decrease in catalytic efficiency.
FT                                {ECO:0000269|PubMed:16714288}.
FT   MUTAGEN     178    178       P->A: 300-fold decrease of the affinity
FT                                for anthranilate, whereas catalytic
FT                                efficiency remains nearly unchanged; when
FT                                associated with A-107.
FT   MUTAGEN     223    223       D->N: Affinity for
FT                                phosphoribosylpyrophosphate is similar to
FT                                that of the wild-type enzyme and
FT                                catalytic efficiency is unchanged.
FT                                {ECO:0000269|PubMed:16714288}.
FT   MUTAGEN     224    224       E->Q: Affinity for
FT                                phosphoribosylpyrophosphate is similar to
FT                                that of the wild-type enzyme and
FT                                catalytic efficiency is unchanged.
FT                                {ECO:0000269|PubMed:16714288}.
FT   HELIX         3     11       {ECO:0000244|PDB:1O17}.
FT   HELIX        18     29       {ECO:0000244|PDB:1O17}.
FT   HELIX        35     48       {ECO:0000244|PDB:1O17}.
FT   HELIX        52     65       {ECO:0000244|PDB:1O17}.
FT   STRAND       75     79       {ECO:0000244|PDB:3GBR}.
FT   HELIX        90     98       {ECO:0000244|PDB:1O17}.
FT   TURN         99    101       {ECO:0000244|PDB:1O17}.
FT   STRAND      104    108       {ECO:0000244|PDB:1O17}.
FT   STRAND      112    115       {ECO:0000244|PDB:1O17}.
FT   HELIX       118    125       {ECO:0000244|PDB:1O17}.
FT   HELIX       133    143       {ECO:0000244|PDB:1O17}.
FT   STRAND      144    149       {ECO:0000244|PDB:1O17}.
FT   HELIX       150    153       {ECO:0000244|PDB:1O17}.
FT   HELIX       155    159       {ECO:0000244|PDB:1O17}.
FT   HELIX       161    167       {ECO:0000244|PDB:1O17}.
FT   HELIX       172    175       {ECO:0000244|PDB:1O17}.
FT   HELIX       177    179       {ECO:0000244|PDB:1O17}.
FT   STRAND      186    191       {ECO:0000244|PDB:1O17}.
FT   HELIX       195    205       {ECO:0000244|PDB:1O17}.
FT   TURN        207    209       {ECO:0000244|PDB:1ZYK}.
FT   STRAND      211    218       {ECO:0000244|PDB:1O17}.
FT   TURN        219    221       {ECO:0000244|PDB:1O17}.
FT   STRAND      222    224       {ECO:0000244|PDB:1O17}.
FT   STRAND      227    237       {ECO:0000244|PDB:1O17}.
FT   STRAND      240    247       {ECO:0000244|PDB:1O17}.
FT   HELIX       248    251       {ECO:0000244|PDB:1O17}.
FT   HELIX       258    260       {ECO:0000244|PDB:1O17}.
FT   HELIX       266    277       {ECO:0000244|PDB:1O17}.
FT   HELIX       282    298       {ECO:0000244|PDB:1O17}.
FT   STRAND      301    304       {ECO:0000244|PDB:1O17}.
FT   HELIX       305    316       {ECO:0000244|PDB:1O17}.
FT   HELIX       319    329       {ECO:0000244|PDB:1O17}.
FT   HELIX       333    340       {ECO:0000244|PDB:1O17}.
SQ   SEQUENCE   345 AA;  37574 MW;  D51927F4B7AAFA90 CRC64;
     MNINEILKKL INKSDLEINE AEELAKAIIR GEVPEILVSA ILVALRMKGE SKNEIVGFAR
     AMRELAIKID VPNAIDTAGT GGDGLGTVNV STASAILLSL VNPVAKHGNR AVSGKSGSAD
     VLEALGYNII VPPERAKELV NKTNFVFLFA QYYHPAMKNV ANVRKTLGIR TIFNILGPLT
     NPANAKYQLM GVFSKDHLDL LSKSAYELDF NKIILVYGEP GIDEVSPIGN TFMKIVSKRG
     IEEVKLNVTD FGISPIPIEK LIVNSAEDSA IKIVRAFLGK DEHVAEFIKI NTAVALFALD
     RVGDFREGYE YADHLIEKSL DKLNEIISMN GDVTKLKTIV VKSSG
//
